The Regenerative Center, LLC acquired Tangible and intangible assets of Kentucky operation of IMAC Holdings, Inc. for $0.08 million.
November 29, 2023
Share
The Regenerative Center, LLC entered into agreements to acquire Tangible and intangible assets of Kentucky operation of IMAC Holdings, Inc. for $0.08 million on November 24, 2023.
The Regenerative Center, LLC completed the acquisition of Tangible and intangible assets of Kentucky operation of IMAC Holdings, Inc. in November 2023.
IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinsonâs disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.